risedronate sodium (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the risedronate sodium drug offered from Actavis Pharma, Inc.. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient],Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | risedronate sodium |
SUBSTANCE NAME: | RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient],Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2014-06-11 |
END MARKETING DATE: | 0000-00-00 |
risedronate sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | risedronate sodium from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 129; 21(mg/1; mg/1) |
START MARKETING DATE: | 2014-06-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0591-2044_7a248a22-542a-4581-8b00-1f87a2febea5 |
PRODUCT NDC: | 0591-2044 |
APPLICATION NUMBER: | NDA020835 |
Other RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE Pharmaceutical Manufacturers / Labelers: